The MiniMed 630G system is an integrated insulin pump with continuous glucose monitoring (CGM) and SmartGuard technology.
Designed exclusively for use with the MiniMed 630G system with SmartGuard technology, the Contour Next Link 2.4 BGMS wirelessly sends highly accurate blood glucose results for CGM calibration and insulin dosing.
It automatically transfers blood glucose results into the MiniMed 630G pump, helping to avoid manual blood glucose entry errors to the pump.
Ascensia Diabetes Care US president Robert Schumm said: “We are delighted that the MiniMed®630G system with the Contour Next Link 2.4 meter will now be available to people with diabetes in the US.
“The accuracy of our blood glucose monitoring system combined with the new innovative technology of the MiniMed® 630G system will truly help people with diabetes manage their condition.”
The MiniMed 630G system with SmartGuard technology will give alarm to alert users when the CGM sensor detects low blood sugar, and suspends insulin delivery if the user is immediately unresponsive to the alarm.
Recently, Ascensia Diabetes Care renewed its partenership with Medtronic to develop and market innovative diabetes management solutions for patients.
Under the deal, the firms will continue to co-develop and supply Contour Next Link and Contour Plus Link BGMSs that wirelessly communicate with compatible Medtronic integrated insulin pump and CGM systems.
